Integrum AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a INTEG-B.ST research report →
Companywww.integrum.se
Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides Osseointegrated Prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket. The OPRA implant system offers protection to the patient by avoiding bone fractures from accidental loads.
- CEO
- Martin Hillsten
- IPO
- 2017
- Employees
- 36
- HQ
- Mölndal, SE
Price Chart
Valuation
- Market Cap
- $174.94M
- P/E
- -5.01
- P/S
- 1.87
- P/B
- 1.04
- EV/EBITDA
- -3.95
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 17.57%
- Op Margin
- -46.52%
- Net Margin
- -40.51%
- ROE
- -22.10%
- ROIC
- -19.57%
Growth & Income
- Revenue
- $91.10M · -12.50%
- Net Income
- $-30,852,000 · -865.09%
- EPS
- $-1.45 · -730.43%
- Op Income
- $-42,375,000
- FCF YoY
- -107.57%
Performance & Tape
- 52W High
- $43.15
- 52W Low
- $6.40
- 50D MA
- $7.59
- 200D MA
- $13.46
- Beta
- 0.36
- Avg Volume
- 43.08K
Get TickerSpark's AI analysis on INTEG-B.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our INTEG-B.ST Coverage
We haven't published any research on INTEG-B.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate INTEG-B.ST Report →